Boundless Bio Appoints Christian Hassig, Ph.D., as Chief Scientific Officer
SAN DIEGO–(BUSINESS WIRE)–Boundless Bio, a company interrogating and targeting extrachromosomal DNA (ecDNA) in aggressive cancers, today announced that Christian (“Chris”)…
Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO–(BUSINESS WIRE)–Boundless Bio, a company interrogating and targeting extrachromosomal DNA (ecDNA) in aggressive cancers, today announced that Christian (“Chris”)…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Generation Bio, a company working to expand the reach of gene therapy through a novel construct and targeted…
FAIRFAX, Va.–(BUSINESS WIRE)–#AmericanCollegeRheumatology—Vizuri Health Sciences LLC, a pharmaceutical development company, today announced that it has been selected to make an…
DUBLIN–(BUSINESS WIRE)–The “Cell Based Assay & High Content Screening Markets Market Forecasts by Application, With Executive and Consultant Guides and…
Data Demonstrated Quantitative Repeatability and Stability of Signal Company Continues to Enroll Subjects as Planned to Complete the Phase 2B…
IRVINE, Calif.–(BUSINESS WIRE)–$NVUS #otitismedia–Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders…
CROs eliminating manual processes and modernizing systems to streamline information exchange and accelerate study start-up PLEASANTON, Calif.–(BUSINESS WIRE)–#CROs–Contract research organizations…
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics…
Total product and royalty revenues of $534 million (+24% vs. Q3 2018) and Jakafi® (ruxolitinib) revenues of $433 million (+25%…
FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment…